Press Releases
Cypherpunk Technologies to Report Third Quarter 2026 Financial Results on November 16, 2026
CAMBRIDGE, Mass., Nov. 10, 2026 /PRNewswire/ -- Cypherpunk Technologies Inc. (Nasdaq: CYPH) ("Cypherpunk"), a privacy technology company, today announced it will report third quarter 2026 financial results on Monday, November 16, 2026.
The Aaon Group Announces Quarterly Cash Dividend
TULSA, Okla., Nov. 10, 2026 /PRNewswire/ -- AAON, Inc. (NASDAQ: AAON), doing business as The Aaon Group, a leader in high-performing, energy-efficient HVAC solutions that bring long-term value to customers and owners, today announced that its Board of Directors has declared the Company's next regular quarterly cash dividend of $0.10 per share (or $0.40 annually), payable on December 17, 2026, to stockholders of record as of the close of business on November 25, 2026...
Endurance Gold Expands Crown and Lower Imperial Zones 7.79 gpt Au & 0.26% Sb over 4.1 Metres including 48.30 gpt Au & 1.68% Sb over 0.6 m
Vancouver, British Columbia--(Newsfile Corp. - November 10, 2026) - Endurance Gold Corporation (TSXV: EDG) (OTCQB: ENDGF) (FSE: 3EG) (the "Company") is pleased to report assay results from five (5) additional diamond drill holes completed at its 100%-owned Reliance Gold Project (the "Project"). In January 2026, the Company reported an inaugural Inferred Mineral Resource Estimate ("MRE") of 19.6 million tonnes at an average grade 2.30 grams per tonne ("gpt") Au, for 1.45 million ounces contained gold (see MRE Disclaimer below)...
TempraMed Granted U.S. Patent for Pen Agnostic, VIVI Cap Smart(TM) Further Strengthens Global Intellectual Property Position
Patent Grant in the U.S. marks a major milestone in global IP strategy, advancing protection of its VIVI Cap Smart(TM) platform Highlights U.S. patent officially granted by the U.S. Patent Office on September 29, 2026 Covers core innovations underpinning TempraMed's VIVI Cap Smart™, which was launched earlier this year Strengthens the Company's global intellectual property position with 39 granted patents and registered designs across multiple jurisdictions, in addition to pending patent and design applications TempraMed portfolio now available across McKesson Medical-Surgical's U.S. B2B network, including Optum Now, physician offices, long-term care and home health, under an expanded agreement signed in June 2026 Online B2C distribution in the U.S. through Amazon, and Walmart Toronto, Ontario--(Newsfile Corp. - November 10, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE: 9DY) (OTCQB: TMPTF) ("TempraMed" or the "Company"), a medical-technology innovator transforming how temperature-sensitive medications are stored and managed, is pleased to announce that its U.S. patent application No...
Gold X2 Intersects 258.4m of 0.97 g/t Au and 192.0m of 0.90 g/t Au in QES Extension Drilling
Vancouver, British Columbia--(Newsfile Corp. - November 10, 2026) - Gold X2 Mining Inc. (NYSE American: AUXX) (TSXV: AUXX) (FSE: DF80) ("Gold X2" or the "Company") is pleased to announce new assay results from exploration drilling targeting the down-dip extension of the QES Zone at the Moss Gold Project in Northwest Ontario, Canada (the "Moss Gold Project"). Michael Henrichsen, CEO and Director of Gold X2, commented: "We are very encouraged by these results, which demonstrate the continuity of broad gold mineralization over approximately 200-metre drill widths with internal high-grade zones well below the current pit shell...
Argentina Metals Announces Additions to Exploration Team in Advance of Upcoming Field Season in Mendoza, Argentina
Vancouver, British Columbia--(Newsfile Corp. - November 10, 2026) - Argentina Metals Corp. (TSXV: VLLC) (OTCQB: VLLCF) (FSE: VA5) ("VLLC" or the "Company") is pleased to announce the appointment of three experienced professionals to strengthen its exploration and operational capabilities ahead of the upcoming field season in Mendoza, Argentina: Alex Raab - Head of Exploration Carlos Giustozzi - Senior Geologist Víctor Rioseco - Head of Logistics "As we prepare for the upcoming field season in Mendoza, we are delighted to welcome Alex, Carlos and Víctor to the Argentina Metals team," said Roger Clegg, Chief Executive Officer of Argentina Metals. "Their combined exploration, technical and operational experience will significantly strengthen our capabilities on the ground as we advance our portfolio of copper projects...
RETRANSMISSION: Bitzero Receives All Long-Lead High-Voltage Equipment for Its Flagship Norway Data Center and Provides Recap in Shareholder Letter from Founder & CEO
Arrival of two 60 MVA transformers completes the high-voltage long-lead package to expand the site to up to 110 MW of total capacity, including 40 MW already energized Vancouver, British Columbia--(Newsfile Corp. - November 10, 2026) - Bitzero Holdings Inc. (NASDAQ: AIBZ) (CSE: AIBZ.U) (FSE: 000) ("Bitzero" or the "Company") today issued the following shareholder letter from Founder, Chair and Chief Executive Officer Mohammed Bakhashwain. Dear Shareholders, The two 60 MVA transformers ordered for our flagship data center site in Namsskogan, Norway (the "Namsskogan Site") have arrived in Norway...
Graphite One Engages Ames National Laboratory to Assess Rare Earth Recoveries from Alaska's Graphite Creek Deposit
Three-month project with the Department of Energy Strategic Special Program will evaluate leaching, heavy and light rare earth separation, and a preliminary scalable process flowsheet VANCOUVER, BC, Nov. 10, 2026 /PRNewswire/ -- Graphite One Inc. (TSXV: GPH) (OTCQX: GPHOF) ("Graphite One," "G1" or the "Company") today announced a research program with Ames National Laboratory ("Ames Lab") to assess and optimize a sustainable process for recovering rare earth elements ("REEs") from garnet material from the Company's Graphite Creek deposit near Nome, Alaska. The work, conducted under a Strategic Partnership Project Agreement, will examine garnet preparation and characterization, acid leaching, separation of heavy rare earth elements ("HREEs") from light rare earth elements ("LREEs"), and product purification...
URBAN ONE, INC. REPORTS THIRD QUARTER 2026 RESULTS
SILVER SPRING, Md., Nov. 10, 2026 /PRNewswire/ -- Urban One, Inc. (NASDAQ: UONEK and UONE, referred to as, "Urban One," the "Company", "we", "our" and/or "us") today reported its results for the three months ended September 30, 2026.
BuildDirect Announces Non-Brokered Private Placement of up to $5,000,000
Proceeds to fund a portion of the purchase price under an executed asset purchase agreement for a strategic acquisition, and for working capital and general corporate purposes NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Vancouver, British Columbia--(Newsfile Corp. - November 10, 2026) - BuildDirect.com Technologies Inc. (TSXV: BILD) (OTCQB: BDCTF) ("BuildDirect" or the "Company"), an omnichannel building materials retailer, is pleased to announce a non-brokered private placement (the "Offering") of up to 2,083,333 common shares of the Company (each, a "Common Share") at a price of $2.40 per Common Share for aggregate gross proceeds of up to approximately $5,000,000. All dollar amounts in this news release are in Canadian dollars unless otherwise stated...
GreenLight Metals Intersects 1.20% Copper and 1.33 g/t Gold over 30.62 Metres at the Bend Project
Includes 6.51 metres at 2.15% copper and 1.71 g/t gold; results support continuity of the eastward-plunging copper-gold zone approximately 55 metres down-dip of B26-015 Medford, Wisconsin--(Newsfile Corp. - November 10, 2026) - GreenLight Metals Inc. (TSXV: GRL) (OTCQB: GRLMF) ("GreenLight" or the "Company") is pleased to announce assay results from drill hole B26-016 at its Bend copper-gold volcanogenic massive sulfide ("VMS") Project in Taylor County, Wisconsin. B26-016 intersected a broad copper-gold interval approximately 55 metres down-dip of B26-015, providing a further test of the eastern continuation of the copper-gold zone...
Excalibur Engages Precision GeoSurveys for Airborne Geophysical Survey at Bellehelen
Vancouver, British Columbia--(Newsfile Corp. - November 10, 2026) - Excalibur Metals Corp. (TSXV: EXCL) (OTCQB: EXCBF) ("Excalibur" or the "Company") is pleased to announce that it has engaged Precision GeoSurveys US Inc. ("Precision") to conduct a high-resolution helicopter-borne magnetic and radiometric survey at the Company's Bellehelen Silver-Gold Project ("Bellehelen" or the "Project") in Nye County, Nevada. The planned 876 line-kilometre survey will cover approximately 79.6 square kilometres and build on airborne data collected by Precision in 2020 to support geological interpretation and exploration target development...
IsoEnergy Increases Strategic Holding in Premier American Uranium Inc.
TORONTO, Nov. 10, 2026 /PRNewswire/ -- IsoEnergy Ltd. ("IsoEnergy", or the "Company") (NYSE American: ISOU) (TSX: ISO) is pleased to announce that it has agreed to acquire (the "Transaction") 13,642,775 common shares (the "PUR Shares") of Premier American Uranium Inc. ("PUR") held by Sachem Cover Opportunity Fund LP ("Sachem Cove") in consideration for the issuance of an aggregate of 387,491 common shares of the Company (the "ISO Shares")...
Opus Genetics Announces Financial Results for Third Quarter 2026 and Provides Corporate Update
OPGx-BEST1 Cohort 2 Dosing Complete and Data Expected in Q1 2027 OPGx-LCA5 Registrational Phase 3 Trial Fully Enrolled with Initiation of Dosing Expected in Q4 2026 FDA Clearance of IND for OPGx-RDH12, with Phase 1/2 Trial Dosing Planned for Q4 2026 FDA Approval of Phentolamine Ophthalmic Solution 0.75% for Presbyopia Triggers Milestone Payment Cash Runway into 2029 Expected to Support Multiple Clinical Inflection Points and Opportunities for Priority Review Vouchers RESEARCH TRIANGLE PARK, N.C., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD) (the “Company” or “Opus Genetics”), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients with inherited retinal diseases (IRDs), today announced financial results for the third quarter ended September 30, 2026, and provided a corporate update...
Millennial Potash Continues to Expand Potash Mineralization as Drillhole BA-007 Intersects Approx. 132m of Cumulative Carnallitite
West Vancouver, British Columbia--(Newsfile Corp. - November 10, 2026) - Millennial Potash Corp. (TSXV: MLP) (OTCQB: MLPNF) (FSE: X0D) ("MLP", "Millennial" or the "Company") is excited to announce continued drilling success at its Banio Potash Project in Gabon, where drillhole BA-007 at the North Target intersected approximately 132m of robust cumulative potash mineralization. Drillhole BA-007, located approximately 2,400m northwest of BA-006 and 2,600m west of BA-002, was completed to a depth of 624.65m...
Chicago Atlantic Real Estate Finance Announces Third Quarter 2026 Financial Results
CHICAGO, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Chicago Atlantic Real Estate Finance, Inc. (NASDAQ: REFI, “Chicago Atlantic”, "REFI" or the “Company”), a commercial mortgage real estate investment trust, today announced its financial results for the third quarter ended September 30, 2026.
ValOre Signs MoU with German Federal Geoscience Agency BGR to Advance Processing of Weathered PGE Mineralization at Pedra Branca
Collaboration within the German government-funded BioPlat research project brings bioleaching and mineral processing expertise to Pedra Branca Collaboration within the German government-funded BioPlat research project brings bioleaching and mineral processing expertise to Pedra Branca
Immatics Announces Third Quarter 2026 Financial Results and Business Update
Houston, Texas and Tuebingen, Germany, November 10, 2026 – Immatics N.V. (NASDAQ: IMTX, “Immatics” or the “Company”), the global leader in precision targeting of PRAME with multiple clinical-stage programs spanning cell therapies and bispecifics, today provided a business update and reported financial results for the quarter ended September 30, 2026...
Olema Oncology Reports Third Quarter 2026 Financial and Operating Results
SAN FRANCISCO, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast cancer and beyond, today reported financial and operating results for the third quarter ended September 30, 2026...
Sionna Therapeutics Reports Third Quarter 2026 Financial Results
Advancing SION-451 + SION-2222 dual combination to AscenSION CF Phase 2 proof-of-concept trial, expected to initiate in the first quarter of 2027
Talamore Mining Corp. Begins Trading on OTCQX Best Market
NEW YORK, Nov. 10, 2026 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Talamore Mining Corp. (TSX: TALA; OTCQX: TALMF), a mineral exploration and development company, has qualified to trade on the OTCQX Best Market. Talamore Mining Corp. upgraded to OTCQX from the OTCQB Venture Market...
Ocugen and Celairis Therapeutics Enter into Exclusive License Agreement for OCU400 in Australia, New Zealand, and ASEAN
MALVERN, Pa. and SYDNEY, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. ("Ocugen" or the "Company") (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, and Celairis Therapeutics Holdings Pty Ltd. ("Celairis"), a Sydney-based in-licensing, development, and commercialization biopharmaceutical company focused on Australia, New Zealand, Taiwan, and ASEAN, today announced the execution of an exclusive license agreement (the "License Agreement") granting Celairis an exclusive license to commercialize OCU400, Ocugen's investigational modifier gene therapy for the treatment of RP, in Australia, New Zealand, and ASEAN markets (the "Territory")...
ENOVA ANNOUNCES NEW $500 MILLION SHARE REPURCHASE PROGRAM
CHICAGO, Nov. 10, 2026 /PRNewswire/ -- Enova International (NYSE: ENVA), a leading financial services company powered by machine learning and world-class analytics, today announced that its Board of Directors has authorized a new share repurchase program totaling $500 million that expires June 30, 2028. Enova's existing $400 million repurchase program that would have expired on June 30, 2027 will terminate and be replaced by this new program...
A NEW DAY AT ETHAN ALLEN
Proven Retail Operator Stefanie Tsen Ward Appointed Interim Chief Executive Officer Stefanie Tsen Ward, Anna Brockway, Lindsay O'Reilly and Adam Treanor Appointed to Board, Providing Robust Oversight and Full Suite of Capabilities to Create Shareholder Value Douglas G. Bergeron Named Executive Chairman and Kristine E...
Gain Therapeutics Reports Financial Results for Third Quarter 2026 and Provides Corporate Update
BETHESDA, Md., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, today reported financial results for the quarter ended September 30, 2026, and provided a corporate update...
Canterra Intersects 18.75 m of 5.35% CuEq, including 5.15 m of 8.83% CuEq, at the Lemarchant Deposit – Demonstrating High-Grade Potential Beyond Lundberg in Newfoundland's Buchans District
Canterra reports 18.75 m of 5.35% CuEq, including 5.15 m of 8.83% CuEq, in hole LM-26-172 at the Lemarchant Deposit in Newfoundland's Buchans District.
Premier American Uranium Completes US$5 Million Strategic Equity Investment by DISA Uranium; IsoEnergy Increases its Strategic Holding
TORONTO, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Premier American Uranium Inc. (“PUR”, the “Company” or “Premier American Uranium”) (TSXV: PUR) (OTCQB: PAUIF) is pleased to announce that it has closed its previously announced strategic equity investment by DISA Uranium Corporation (“DISA Uranium”), pursuant to which PUR issued 9,326,000 subscription receipts (the “Subscription Receipts”) to DISA Uranium at C$0.75 per Subscription Receipt (the “Offering Price”) for aggregate proceeds of US$5,000,000 (C$6,994,500) (the “Equity Investment”). Upon conversion of the Subscription Receipts, DISA Uranium is expected to hold an approximately 8.88% ownership interest in PUR. The Offering Price represents a 41.5% premium to the closing price of PUR's common shares (the “PUR Shares”) on September 14, 2026, the last trading day prior to the announcement of the Equity Investment...
Allstate Thanksgiving Driver Report: What drivers should know before hitting the road
High-speed driving jumps nearly 200% Thanksgiving morning, according to Allstate Drivewise data, with new insights showing when and where drivers should take extra care. Key takeaways: Allow extra time.
LENSAR® Reports Third Quarter 2026 Financial Results and Provides Business Update
10 ALLY Robotic Cataract Laser Systems (“ALLY System”) Placements in Third Quarter 2026; Backlog of 12 ALLY Systems as of September 30, 2026 Third Quarter Recurring Revenue Grew 17% Year Over Year to $12.6 Million Total Laser Installed Base Reaches 450 Systems; ALLY System Installed Base Expands 22% Year Over Year ORLANDO, Fla., Nov. 10, 2026 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”), a global medical technology company focused on advanced robotic laser solutions for the treatment of cataracts, today announced financial results for the quarter ended September 30, 2026 and provided an update on key operational initiatives...
CalciMedica Reports Third Quarter 2026 Financial Results and Provides Clinical & Corporate Updates
Auxora Phase 1b proof-of-concept data in pulmonary hypertension (PH) and CM5480 IND submission both anticipated in mid-2027
Upstream Bio Reports Third Quarter 2026 Financial Results and Highlights Continued Progress
– Company plans to initiate Phase 3 trials in both severe asthma and CRSwNP in the first quarter of 2027 –
Compugen to Present UnigenX™ Platform at the 18th Annual PEGS Europe Summit
HOLON, Israel, Nov. 10, 2026 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery powered by AI, today announced an oral presentation at the 18th Annual Protein and Antibody Engineering Summit (PEGS) Europe, taking place November 16-19, 2026, in Lisbon, Portugal...
FactSet Hosts Investor Day 2026
Details Strategy and Medium-Term Outlook Through Fiscal 2029; Reaffirms Fiscal 2027 Outlook NORWALK, Conn., Nov. 10, 2026 (GLOBE NEWSWIRE) -- FactSet (NYSE: FDS | NASDAQ: FDS), a leading global intelligence and AI solutions provider to the financial markets, will host its Investor Day today in New York City at 9:00 a.m...
Autolus Therapeutics Reports Third Quarter 2026 Financial Results and Business Updates
Company reports AUCATZYL (obecabtagene autoleucel; obe-cel) net product revenue of $41.2 million, an increase of 95% year-over-year; now expects full-year 2026 AUCATZYL net product revenue to be at or exceeding upper end of $150 million from prior guidance Gross margin increased to 57%, driven by growing volumes and manufacturing efficiency initiatives Obe-cel clinical development programs progressing with trial enrollment ongoing in lupus nephritis, pediatric ALL and progressive multiple sclerosis (MS) Conference call to be held today at 8:30am EST/1:30pm GMT: conference call participants should pre-register using the link at the bottom of this press release LONDON and GAITHERSBURG, Md., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies and candidates, today announces its operational and financial results for the third quarter ended September 30, 2026...
Legend Biotech Reports Third Quarter 2026 Results and Recent Highlights
CARVYKTI (ciltacabtagene autoleucel; cilta-cel) net trade sales increased 36% versus third quarter of 2025 to approximately $710 million Half of CARTITUDE-2 Cohort A patients remained alive and progression-free without further anti-myeloma treatment five years after a single CARVYKTI infusion, adding to growing long-term evidence supporting the curative potential of CARVYKTI in earlier-line RRMM Updated NCCN Guidelines recommend that all patients with multiple myeloma be referred to a T-cell therapy capable center at first relapse for consideration of available therapies Received U.S. FDA IND clearance for LB2501, an investigational CD19/CD20 dual-targeting in vivo CAR‑T therapy for relapsed or refractory B-cell malignancies Appointed Ingrid Zhang as Chief Executive Officer Cash and cash equivalents, and time deposits of approximately $853 million, as of September 30, 2026 BRIDGEWATER, N.J., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today reported its third quarter 2026 unaudited financial results and recent highlights...
City Therapeutics Announces First Participant Dosed in Phase 1 Clinical Trial of CITY-RBP4 for the Treatment of Stargardt Disease
CITY-RBP4 is an RNAi therapeutic candidate designed to provide potent and durable suppression of RBP4, a clinically supported target in Stargardt disease City's second program to advance into the clinic, demonstrating strong momentum across the pipeline CAMBRIDGE, Mass., Nov. 10, 2026 (GLOBE NEWSWIRE) -- City Therapeutics, Inc. (Nasdaq: CTY), a clinical-stage biotechnology company engineering the next generation of RNA interference (RNAi) therapeutics, today announced that the first participant has been dosed in the Phase 1 clinical trial of CITY-RBP4, an investigational RNAi therapeutic candidate for the treatment of Stargardt disease type 1 (Stargardt disease)...
WRAP Appoints Eric Bowen as Chief Operating Officer to Drive Execution and Scale Its Non-Lethal Response Business
MIAMI, Nov. 10, 2026 (GLOBE NEWSWIRE) -- WRAP Technologies, Inc. (NASDAQ: WRAP) (“WRAP” or the “Company”), a global public safety technology company focused on non-lethal response and on intelligent detection, orchestration and response solutions for the next generation of human-centered public safety, today announced the appointment of Eric Bowen as Chief Operating Officer, effective November 16, 2026. Bowen brings more than a decade of experience building and running the operating engine of a technology company that sells mission capability to U.S. federal, state and local, and allied government customers...
Harvard Bioscience Announces Third Quarter 2026 Financial Results
Third Quarter 2026 Revenue Growth of 8% Year Over Year to $22.2 Million Reaffirms Full Year 2026 Revenue Guidance of 3%-5% Year Over Year Growth HOLLISTON, Mass., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company” or “Harvard Bioscience”) today announced financial results for the third quarter ended September 30, 2026...
Kailera Therapeutics to Present at ObesityWeek 2026
Ribupatide injection Phase 3 KaiNETIC trial design presentations highlight its potential to address diverse needs across the obesity spectrum Real-world obesity management presentation highlights the clinical unmet needs of people living with obesity WALTHAM, Mass., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Kailera Therapeutics, Inc. (Nasdaq: KLRA) (Kailera), a clinical-stage biotechnology company focused on elevating the next era of obesity care, today announced that new clinical and real-world research will be presented at ObesityWeek 2026, taking place November 14-17 in Washington, D.C...
etoro Reports Third Quarter 2026 Results
Funded accounts grew by 18% year-over-year to 4.39 million Announced $ 2 5 0 million share repurchase program NEW YORK, Nov. 10, 2026 (GLOBE NEWSWIRE) -- etoro Group Ltd. (“etoro”, or the “Company”) (NASDAQ: ETOR), the trading and investing platform, today announced financial results for the third quarter ended September 30, 2026...
Ovid Therapeutics Reports Business Updates and Third Quarter 2026 Financial Results
OV329 is advancing in a global, Phase 2 focal epilepsy study expected to read out in H2 2027 Ovid is enrolling patients in ongoing photosensitivity study intended to demonstrate the anticonvulsant effect of OV329; results expected in early 2027 OV4071, the first-ever oral KCC2 direct activator, continues to progress in a Phase 1 single- and multiple-ascending dose study; translational ketamine challenge study ready for initiation Advancement of a pediatric formulation of OV329 is on track and Company plans to initiate a study in TSC-associated seizures before year-end 2026, representing the first indication in a broad potential DEE franchise Cash, cash equivalents and marketable securities were $161.4 million as of September 30, 2026; expected financial runway into 2029 NEW YORK, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company dedicated to pioneering better, gentler medicines for brain disorders with significant unmet need, today provided business updates including financial results for the third quarter ended September 30, 2026. “The third quarter was focused on execution toward multiple, near-term clinical milestones across our pipeline,” said Meg Alexander, President and Chief Executive Officer...
Cullinan Therapeutics Provides Corporate Update and Reports Third Quarter 2026 Financial Results
CLN-978 (CD19 TCE) multi-dose regimen data in SLE, RA, and Sjögren's disease will be shared in December Velinotamig (BCMA TCE) data presented at ACR Convergence 2026; global Phase 1/2 study in autoimmune cytopenias initiated CLN-049 (FLT3 TCE) potentially registrational Phase 2 study in R/R AML underway; updated data from the Phase 1 dose escalation study will be presented at the 2026 ASH Annual Meeting Zipalertinib NDA submission for first-line combination therapy in EGFR ex20ins NSCLC initiated under U.S. FDA Real-Time Oncology Review program; completion expected in November Cash and investments of $313.8 million as of September 30, 2026; runway into 2029 CAMBRIDGE, Mass., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (Nasdaq: CGEM; “Cullinan”), a clinical-stage biopharmaceutical company accelerating potential first- or best-in-class, disease-modifying T cell engagers in autoimmune diseases and cancer, today provided an update on recent and anticipated business highlights and announced its financial results for the third quarter ended September 30, 2026...
Beam Therapeutics Announces Positive Topline Pivotal Data from BEACON Phase 1/2 Trial of Risto-cel in Patients with Sickle Cell Disease
BEACON Trial Achieved Primary Efficacy Endpoint of Freedom from Severe Vaso-occlusive Crises (VOCs) for at Least 12 Consecutive Months, Based on Independently Adjudicated Results, and Met All Primary Safety Endpoints at the Prespecified Interim Analysis Study Met All Secondary Endpoints Including Freedom from Inpatient Hospitalization for Severe VOCs for 12 Consecutive Months Results Support Planned U.S. Biologics License Application (BLA) Submission for risto-cel, Expected as Early as Year-End 2026 CAMBRIDGE, Mass., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced positive topline results from the BEACON Phase 1/2 study evaluating ristoglogene autogetemcel (risto-cel) in patients with sickle cell disease (SCD) with severe vaso-occlusive crises (VOCs)...
Humacyte Reports Third Quarter 2026 Results, Highlighted by More Than Doubling Symvess Revenue and Expanding Commercial Adoption
– Commercial adoption of Symvess accelerated during the third quarter with sales totaling $1.0 million, a 151% increase over the 2 nd quarter. – Symvess commercial momentum continued into the fourth quarter, with October 2026 sales totaling $0.8 million.
PyroGenesis Announces Third Titanium Powder Contract with U.S. Applied Research Lab
MONTREAL, Nov. 10, 2026 (GLOBE NEWSWIRE) -- PyroGenesis Inc. (“PyroGenesis” or the “Company”) (TSX: PYR) (OTCQX: PYRGF) (FRA: 8PY1), a leader in ultra-high temperature processes and engineering innovation, and a plasma-based technology provider to heavy industry & defense, announces today a third contract with an existing client for titanium powder produced by PyroGenesis' NexGen™ plasma atomization process. The client is one of the largest applied research laboratories supported by the U.S. Department of Defense and NASA, who previously placed orders with PyroGenesis on August 20 and August 26 , 2026...
Nurix Therapeutics to Participate in Upcoming Investor Conferences
BRISBANE, Calif., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein degradation medicines, today announced that Company management will participate in fireside chats at the following investor conferences: UBS Global Biopharma Conference Tuesday, November 17, 2026, at 2:40 p.m...
Freightos Launches Next-Generation Forwarder Platform, Advancing from Digital Workflows to an AI-Native Freight Orchestration Network
Connected carrier data, market intelligence, quoting, booking, and AI-native workflows deliver faster execution, eliminate administrative drag, protect margins, and accelerate commercial growth BARCELONA, Spain, Nov. 10, 2026 /PRNewswire/ -- Freightos Limited (NASDAQ: CRGO), the leading vendor-neutral global freight pricing, booking, and procurement platform, today announced the launch of the next-generation of Freightos for Forwarders for air and ocean. The platform advances Freightos' established digital commerce and workflow capabilities into an intelligent, AI-native freight orchestration network that unifies rates, quoting, booking, and market intelligence in one connected environment...
Hemab Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update
Dosed first participant in Phase 1 clinical trial of HMB-003 for management of heavy menstrual bleeding, a condition affecting more than 23 million women in the U.S. alone Announced data showing HMB-003 reduced severe menstrual bleeding in a cynomolgus monkey model; data to be presented at the 68th ASH Annual Meeting and Exposition in December 2026 Announced first clinical data for sutacimig in Factor VII deficiency (FVIID), showing shortening of prothrombin time by more than 50% in both participants and ~5x accumulation of endogenous FVII(a) in the participant with PK/PD data, after a single dose; updated Phase 2b data to be presented at ASH in December 2026 Initiated SOLARA, a pivotal Phase 3 trial of once-weekly subcutaneous sutacimig in Glanzmann thrombasthenia (GT), the first pivotal trial of a subcutaneous prophylactic treatment in GT Expects to present data from the ongoing VELORA Pioneer Phase 1/2 trial of HMB-002 in Von Willebrand Disease at the 20th EAHAD (European Association for Haemophilia and Allied Disorders) Congress in February 2027 Strengthened Board of Directors with the appointment of Keli Walbert bringing two decades of commercial leadership and proven track record of successful launches to Hemab CAMBRIDGE, Mass. and COPENHAGEN, Denmark , Nov. 10, 2026 (GLOBE NEWSWIRE) -- Hemab Therapeutics (Nasdaq: COAG), a clinical-stage biotechnology company developing therapies that reimagine the treatment of blood coagulation disorders to sustain life and human resilience, today announced financial results for the third quarter ended September 30, 2026, and recent business highlights...
Fate Therapeutics Presents New FT819 Data at ACR Convergence 2026 Highlighting Meaningful Clinical Responses in Lupus Without the Use of Conditioning Chemotherapy
Updated safety data of 36 patients treated with FT819 across three regimens and four autoimmune disease indications with no dose-limiting toxicities continues to be favorable 100% (3 of 3) of extrarenal lupus patients treated with FT819 without the use of conditioning chemotherapy experienced measurable responses with two patients achieving the Definition of Remission in Systemic Lupus Erythematosus (DORIS) and the third achieving Lupus Low Disease Activity State (LLDAS) First patient treated with two doses of FT819 achieved a significant reduction of Systemic Lupus Erythematosus Disease Activity Index (SLEDAI-2K) by 8 points at Month 1, achieving LLDAS by Month 2, which was sustained at Month 3 New preclinical data show FT839 eliminates a broad spectrum of activated immune cells in models of rheumatoid arthritis supporting immune cell reset in multicellular disease; COMPLETE™ Phase 1/2 basket trial open for enrollment SAN DIEGO, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a transformative and broadly accessible pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune disease, today announced that updated clinical data for FT819, together with translational and patient-perspective data, as well as preclinical data for FT839, are being presented in four presentations at the American College of Rheumatology (ACR) Convergence 2026, held November 6–11 in Orlando, Florida. "Our recent clinical data presented at ACR continues to show that FT819 can be delivered in a safe and effective manner that fits into routine rheumatology care," said Bob Valamehr, Ph.D...
Biomea Fusion Announces Poster Presentation of Phase 1 Results for BMF-650, its Investigational Next-Generation Oral Small Molecule GLP-1 Receptor Agonist, at ObesityWeek® 2026
SAN CARLOS, Calif., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage biopharmaceutical company focused on diabetes and obesity, today announced that it will present Phase 1 clinical results for BMF-650, its investigational next-generation oral small molecule GLP-1 receptor agonist, at ObesityWeek 2026...
IBM Impact Accelerator Brings AI and Quantum to the Future of Learning and Work
NEW YORK, Nov. 10, 2026 /PRNewswire/ -- IBM (NYSE: IBM) today announced four organizations selected for the new education and workforce development cohort of the IBM Impact Accelerator, a pro bono social innovation program that provides grants of IBM technology and expertise to help nonprofit and government organizations to design, develop and scale technology-enabled solutions to challenges facing communities around the world. AI is changing the skills employers need and how students and workers navigate the labor market...
Bitdeer Reports Unaudited Third Quarter 2026 Results: Record Revenue of US$320.7 Million; Adjusted EBITDA Up 173% to US$69.6 Million
SINGAPORE, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Bitdeer Technologies Group (NASDAQ: BTDR) (“Bitdeer” or the “Company”), a world-leading technology company for AI neocloud services and Bitcoin mining infrastructure, today released its unaudited financial results for the third quarter ended September 30, 2026. Q3 2026 Financial 1 Highlights All amounts compared to Q3'25 unless otherwise noted Total revenues were a record US$320.7 million, up 89% vs...
Aurora Mobile's EngageLab Powers Real-Time Engagement for Purrrr's Global IoT Cat Rescue Platform
SINGAPORE, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Aurora Mobile Limited (NASDAQ: JG) ("Aurora Mobile" or the "Company"), a leading provider of customer engagement and marketing technology services, today announced that Purrrr, a global IoT app dedicated to stray cat rescue, has integrated EngageLab AppPush to support real-time notifications and user engagement across its growing network of smart feeders. Purrrr is a global community cat care and rescue IoT platform, it connects smart feeding devices with cat lovers worldwide...
WhiteFiber, Inc. Reports Third Quarter 2026 Results
NEW YORK, Nov. 10, 2026 /PRNewswire/ -- WhiteFiber, Inc. (Nasdaq: WYFI) ("WhiteFiber" or the "Company"), a leading provider of AI infrastructure and high-performance computing solutions, today announced financial results for the third quarter ended September 30, 2026. Sam Tabar, Chief Executive Officer of WhiteFiber, said: "NC-1 is now fully operational across all 40 MW of contracted IT capacity, and we have entered into a $300 million secured financing facility for the project...
908 Devices Reports Third Quarter 2026 Financial Results and Achieves Record Revenue
BURLINGTON, Mass.--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety, and defense tech applications, today reported financial results for the quarter ended September 30, 2026. "We had a strong third quarter, driven by our FTIR portfolio, with revenue growing 35% year-over-year to $19 million and device shipments reaching a new company record,” said Kevin J. Knopp, CEO and Co-founde...
Indra Selects Ouster's Digital Lidar for Its Global Electronic Toll Collection Projects
SAN FRANCISCO--(BUSINESS WIRE)--Ouster, Inc. (Nasdaq: OUST), a leader in sensing and perception for Physical AI, and Indra, a global leader in technology and engineering solutions for air traffic control, mobility, defense, and digital transformation, announced Indra's selection of Ouster's 3D digital lidar sensors to enhance detection capabilities across its electronic toll collection projects. Indra has already deployed hundreds of Ouster's Rev7 sensors across the Americas and Europe. Indra's...
Quarterhill Reports Third Quarter 2026 Financial Results
TORONTO, Nov. 10, 2026 /PRNewswire/ -- Quarterhill Inc. ("Quarterhill" or the "Company") (TSX: QTRH) (OTCQX: QTRHF), a leading technology innovator providing next-generation, AI-driven Intelligent Transportation System ("ITS") solutions, today reported financial results for the third quarter ended September 30, 2026. All financial information in this press release is reported in USD unless otherwise indicated...
Alliance Laundry Reports Third Quarter 2026 Results
RIPON, Wis.--(BUSINESS WIRE)--Alliance Laundry Holdings Inc. (NYSE: ALH) (“Alliance” or the “Company”), the global leader in commercial laundry equipment, today announced results for its third quarter ended September 30, 2026 and updated full-year guidance. “Our third quarter results reflect our deep commitment to customers and the strength, resilience and non-discretionary nature of our business model,” said Michael Schoeb, CEO of Alliance. “We continue to invest in our business by expanding o...
Redwire Selected for $40 Million Contract to Demonstrate Power Generation for NASA Moon Base Program Leveraging its Innovative Roll Out Solar Array Technology
JACKSONVILLE, Fla.--(BUSINESS WIRE)---- $RDW--Redwire Corporation (NYSE: RDW), a leader in space infrastructure for the next generation space economy, announced today that it has been selected for an approximately $40 million award to provide an integrated power generation system to support NASA's pioneering Moon Base efforts. Redwire will adapt its flight-proven Roll-Out Solar Array (ROSA) technology as the core part of a power generation system that will serve as a pathfinder for providing interfaces...
Oshkosh Defense Supports Sustained U.S. Army Demand for FMTV A2 LVAD Fleet
OSHKOSH, Wis.--(BUSINESS WIRE)--Oshkosh Defense, an Oshkosh Corporation [NYSE: OSK] business, today announced it has received an additional $31 million order from the U.S. Army for Family of Medium Tactical Vehicles (FMTV) A2 Low-Velocity Airdrop (LVAD) M1081 4x4 and 6x6 Cargo vehicles to advance its FMTV A2 fleet. Following more than $75M in orders in 2026, this contract reflects the U.S. Army's continued investment in the FMTV A2 LVAD capability and supports the delivery of mission-ready vehi...
WEBTOON Entertainment Inc. to Participate in Upcoming Investor Conferences
LOS ANGELES, Nov. 10, 2026 (GLOBE NEWSWIRE) -- WEBTOON Entertainment Inc. (Nasdaq: WBTN) (“WEBTOON Entertainment” or “the Company”), a leading global entertainment company and home to some of the world's largest storytelling platforms, today announced that President Yongsoo Kim and CFO David J. Lee will participate in the following upcoming investor conferences: J.P...
Garmin and Waze team up to amplify the power of community-driven awareness for cyclists and drivers
Industry-first collaboration alerts drivers using the Waze app to nearby Garmin cyclists OLATHE, Kan., Nov. 10, 2026 /PRNewswire/ -- Garmin (NYSE: GRMN) today announced a first-of-its-kind collaboration with Waze ™, the community-driven navigation app used by 200 million drivers around the world.
Quanta Services to Participate in Institutional Investor Conferences in November and December
Baird Global Industrial Conference UBS Global Industrials & Transportation Conference HOUSTON, Nov. 10, 2026 /PRNewswire/ -- Quanta Services, Inc. (NYSE: PWR) announced today that company management will participate in institutional investor conferences in November and December, including the Baird Global Industrial Conference and the UBS Global Industrials & Transportation Conference. Baird 2026 Global Industrial Conference Duke Austin, Chief Executive Officer, Jayshree Desai, Chief Financial Officer, and Kip Rupp, Vice President – Investor Relations, will meet with institutional investors during the conference on November 11, 2026, in Chicago...
Ryder CEO John Diez to Address Stephens Annual Investment Conference
MIAMI--(BUSINESS WIRE)--Ryder System, Inc. (NYSE: R) CEO John Diez to address the 2026 Stephens Annual Investment Conference. Who: Ryder System, Inc. CEO John Diez What: Stephens Annual Investment Conference When: Tuesday, November 17, 2026 Time: 8:45 a.m. CST Webcast: To access the live webcast, visit Ryder System - Stephens Annual Investment Conference. About Ryder System, Inc. Ryder System, Inc. (NYSE: R) is a nearly $13 billion leading provider of outsourced logistics and transportation ser...
Five Point Infrastructure Announces Sale of Deep Blue Midland Basin to Diamondback Energy and KKR
HOUSTON--(BUSINESS WIRE)--Five Point Infrastructure LLC (“Five Point”) today announced that it has entered into a definitive agreement to sell its majority interest in Deep Blue Midland Basin LLC (“Deep Blue”), a produced-water infrastructure platform serving the Midland Basin, to Deep Blue's current minority owner, Diamondback Energy, Inc. (NASDAQ: FANG) (“Diamondback”), and KKR, for cash consideration. The sale of Deep Blue reflects an active period of investment, development and monetization...
Diamondback Energy and KKR to Acquire Deep Blue Midland Basin from Five Point Infrastructure
MIDLAND and HOUSTON, Texas, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Diamondback Energy, Inc. (NASDAQ: FANG) (“Diamondback”) and KKR, a leading global investment firm, today announced an agreement to jointly acquire Five Point Infrastructure's (“Five Point”) 70% stake in Deep Blue Midland Basin LLC (“Deep Blue” or the “Company”), the leading full-cycle water infrastructure platform in the Midland Basin. Following the transaction, Diamondback and KKR will jointly own 100% of Deep Blue, building on Diamondback's existing 30% ownership interest...
Protalix BioTherapeutics Reports Third Quarter 2026 Financial and Business Results
Company to host conference call and webcast today at 8:00 a.m. ET Total revenues increased by $32.0 million year to date to $75.6 million, from $43.6 million for the same period in 2025 Net income was $4.0 million for the third quarter, up from $2.4 million in the third quarter of 2025, and net income was $26.1 million for the nine months ended September 30, 2026 Management expects to meet or exceed 2026 guidance for total revenues of approximately $78.0 million to $83.0 million The PRX-115 Phase 2 RELEASE study remains on track, aiming to improve adherence and durability of response in uncontrolled gout, a substantial unmet need; top-line results anticipated in the second half of 2027 Cash, cash equivalents, and short-term bank deposits were $48.5 million as of September 30, 2026 CARMIEL, Israel, Nov. 10, 2026 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the discovery, development, production, and commercialization of innovative therapeutics for rare diseases with significant unmet needs, today reported financial results for the third quarter ended September 30, 2026, and provided a business and clinical update...
CMC Announces CFO Retirement and Succession Plan; Appoints Kenji Hashimoto as Deputy CFO
IRVING, Texas, Nov. 10, 2026 /PRNewswire/ -- CMC (NYSE: CMC) (the "Company") today announced the planned retirement of Paul Lawrence, who has served as the Company's Senior Vice President and Chief Financial Officer since 2019. The Company also announced a succession plan for the chief financial officer role, with the appointment of Kenji Hashimoto as Senior Vice President and Deputy Chief Financial Officer, effective November 16, 2026...
GFL Environmental Concludes Review of Unsolicited Inbound Proposals; Board Unanimously Reaffirms Strategy to Remain Public
MIAMI BEACH, FL, Nov. 10, 2026 /PRNewswire/ -- GFL Environmental Inc. (NYSE: GFL) (TSX: GFL) ("GFL" or the "Company") today confirmed that a Special Committee of the Board of Directors (the "Board") has concluded its previously announced process to review unsolicited proposals to acquire the Company and take it private. The Special Committee, comprised entirely of independent directors, undertook a comprehensive evaluation with the assistance of independent financial and legal advisors...
Lazard Reports October 2026 Assets Under Management
NEW YORK, Nov. 10, 2026 /PRNewswire/ -- Lazard, Inc. (NYSE: LAZ) reported today that its preliminary assets under management ("AUM") as of October 31, 2026 totaled approximately $282.4 billion. The month's AUM included market depreciation of $1.9 billion, FX depreciation of $1.4 billion, and net inflows of $1.7 billion...
Sally Beauty Holdings Reports Fourth Quarter and Full Year 2026 Results; Delivers Sales, Operating Earnings and Double-Digit EPS Growth in the Fourth Quarter
PLANO, Texas--(BUSINESS WIRE)--Sally Beauty Holdings, Inc. (NYSE: SBH) (the “Company”), the leader in professional hair color, today announced financial results for its fourth quarter and full year ended September 30, 2026. The Company will hold a conference call today at 7:30 a.m. Central Time to discuss these results and its business. “We finished fiscal 2026 with positive momentum, delivering fourth quarter sales, operating earnings and double-digit adjusted EPS growth,” said Denise Paulonis...
Hecla Mining Company Announces Redemption of All Outstanding Shares of Its Series B Cumulative Convertible Preferred Stock
COEUR D'ALENE, Idaho--(BUSINESS WIRE)--Hecla Mining Company (NYSE: HL) today announced that it has called for redemption of all the outstanding shares of its Series B Cumulative Convertible Preferred Stock (NYSE: HL-PB) (the "Series B Preferred Stock"). The redemption will take place on December 11, 2026 (the "Redemption Date").Redemption TermsRedemption Price. Each share outstanding on the Redemption Date will be redeemed for $50.00 plus all accrued and unpaid dividends up to the Redemption Dat...
NIQ Launches New Shelf Architect Capability to Help Manufacturers Drive Store-Level Assortment Growth
CHICAGO--(BUSINESS WIRE)--NielsenIQ (NYSE: NIQ), a leading consumer intelligence company, today announced the U.S. launch of Shelf Architect Store Assortment, a new capability within the Shelf Architect platform. Designed for manufacturer teams, Shelf Architect Store Assortment provides store- and cluster-level assortment recommendations that reflect local demand and support retailer shelf execution. Assortment decisions are often built around national plans and average-store assumptions, even...
BRIGHTSTAR LOTTERY PLC REPORTS THIRD QUARTER 2026 RESULTS
Third quarter revenue of $607 million impacted by higher non-cash service revenue amortization Operational growth drivers accelerated, driving 4% expansion, led by global product sales and other service revenue Income from continuing operations of $45 million; Adjusted EBITDA of $289 million in line with expectations bolstered by improved product sales mix and cost efficiencies Over $200 million deployed for cash dividends and share repurchases year-to-date through November 9 Updating revenue and Adjusted EBITDA outlook for the year; maintaining cash from operations outlook LONDON, Nov. 10, 2026 /PRNewswire/ -- Brightstar Lottery PLC (NYSE:BRSL) ("Brightstar" or the "Company") today reported financial results for the third quarter ended September 30, 2026. Today, at 8:00 a.m...
Enghouse Systems to Acquire MIND C.T.I. in All-Cash Transaction Expanding its Telecom and Enterprise UC Offerings
MARKHAM, ON, Nov. 10, 2026 /PRNewswire/ -- Enghouse Systems Limited (TSX: ENGH) ("Enghouse"), a leading global provider of enterprise software solutions serving select enterprise vertical markets, today announced the execution of a merger agreement by which Enghouse will acquire MIND C.T.I. Ltd. (Nasdaq: MNDO) ("MIND CTI"), a leading provider of business support systems ("BSS") for telecommunications service providers, enterprise unified communications (UC) analytics and messaging solutions...
Lithium Argentina Reports Third Quarter 2026 Results
ZUG, Switzerland, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Lithium Argentina AG (“Lithium Argentina” or the “Company”) (TSX: LAR) (NYSE: LAR) today announced its third quarter 2026 results. Unless otherwise stated, results are presented in United States dollars.
Altamira, a Parsons Company, Awarded $63 Million NOVASTAR Contract
Key Takeaways: Parsons' subsidiary Altamira was awarded a $63 million, four-year task order from the National Air & Space Intelligence Center (NASIC) to support and enhance the Collaboration Collection under the Services of Common Concern program. The work includes sustaining, maintaining, and advancing secure collaboration software and services that enable effective information sharing across mission-critical intelligence environments...
Black Diamond Therapeutics Announces Positive Updated Silevertinib Phase 2 Results, FDA Feedback Supporting a Clear Path to Potential Registration in 1L EGFR-NCM NSCLC, and Provides Corporate Update
CAMBRIDGE, Mass., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer, including silevertinib, a potential best-in-class brain-penetrant epidermal growth factor receptor (EGFR) inhibitor, today reported updated data from its Phase 2 trial of silevertinib in frontline non-small cell lung cancer (NSCLC) patients with EGFR non-classical mutations (NCMs), the outcome from its End of Phase 2 meeting with the U.S. Food and Drug Administration (FDA) and associated Phase 3 plans, and financial results for the third quarter ended September 30, 2026...
Christina Lake Cannabis Concludes Review of Unsolicited Proposals and Will Remain Independent
CLC's Special Committee rejects unsolicited proposals, concluding that a stronger outlook and 2026 harvest support greater value as an independent company
Hyperscale Data Sells Remaining Bitcoin Reserves to Reduce Debt and Fund Michigan AI Data Center
LAS VEGAS, Nov. 10, 2026 /PRNewswire/ -- Hyperscale Data, Inc. (NYSE American: GPUS), an artificial intelligence ("AI") data center company ("Hyperscale Data" or the "Company"), today announced that as of November 8th, 2026, it had sold all of its remaining Bitcoin reserves at approximately $76,000 per Bitcoin. The Company sold approximately 211.56 Bitcoin and received gross proceeds of approximately $16.0 million...
Vireo Growth Inc. Announces Third Quarter 2026 Results
Q3 GAAP revenue of $253.7 million increased 177% year-over-year, driven by recently closed M&A transactions. Q3 proforma revenue of $277.0 million, gives effect to the acquisitions of C21 Investments, certain PharmaCann Colorado assets, and the Cannabist Colorado assets under MSA as if they were completed on July 1, 2026...
Trane Technologies and Goodwill Industries International Team Up to Expand Pathways to Skilled Trades and Clean Tech Careers
SWORDS, Ireland--(BUSINESS WIRE)--Trane Technologies (NYSE: TT), a global climate innovator, today announced a $1 million grant over three years to Goodwill Industries International (GII) to expand the Goodwill Clean Tech Accelerator™ (GCTA), a national training program that helps job seekers facing barriers to employment prepare for entry-level, high-demand careers in the growing clean energy economy. The Goodwill Clean Tech Accelerator is an intensive four- to five-week workforce development...
Cognizant dedicates more than 25,000 professionals to Claude delivery, introduces managed services model to run Claude at the core of enterprise operations
Cognizant's new Claude Frontier Capability Group brings more than 25,000 professionals together in a dedicated global Claude delivery organization. Cognizant's new managed services model gives clients one accountable partner for running Claude in production, with more predictable AI spend and enterprise-grade controls...
Zepp Health Corporation to Report Third Quarter 2026 Financial Results on November 22, 2026
Earnings Call Scheduled for 8:30 p.m. ET on November 22 , 2026 MILPITAS, Calif.
Sea Limited Reports Third Quarter 2026 Results
SINGAPORE--(BUSINESS WIRE)--Sea Limited (NYSE: SE) (“Sea” or the “Company”) today announced its financial results for the third quarter ended September 30, 2026. In the third quarter of 2026, Sea's GAAP revenue was US$8.6 billion, up 43.4% year-on-year. The Company also achieved gross profit of US$3.9 billion, up 51.4% year-on-year, and net income of US$502.5 million, up 34.0% year-on-year. Adjusted EBITDA1 increased by 28.9% year-on-year to reach US$931.3 million. “Our strong momentum from the...
Sono Group N.V. Reports Third Quarter 2026 Results: Swings to Net Income in First Full Quarter as Only a Bitcoin Treasury Company
LAND O'LAKES, FL, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Sono Group N.V. (Nasdaq: SSM) (hereafter referred to as “Sono” or the “Company”) today announced its financial results for the third quarter ended September 30, 2026 and the first nine months of 2026.
VIAVI Joins ORBIT Consortium to Bring Digital Twin Technology to Private 5G on Blackpool's Trams and Buses
RAN digital twin modeling to plan and validate multi-vendor Open RAN deployment in a live public transport environment CHANDLER, Ariz., Nov. 10, 2026 /PRNewswire/ -- VIAVI Solutions Inc. (VIAVI) (NASDAQ: VIAV) has announced its participation in ORBIT (Orchestrated mobile Network for Blackpool intelligent transport), a collaborative project funded by the UK Department for Culture, Media and Sport (DCMS) and Innovate UK...
Nova Minerals Confirms 216,000 tpa Processing Capacity, Advancing Alaska's Critical Minerals Hub
Anchorage, Alaska, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Nova Minerals Corp (“Nova” or the “Company”) (NYSE American: NVA | ASX: NVA) is pleased to announce that an engineering and processing capacity assessment of its newly acquired processing plant, which is to be constructed at Port MacKenzie, Alaska, has confirmed front-end crushing, grinding and concentration capacity of approximately 216,000 tonnes per annum (tpa). This substantial processing capacity provides a scalable platform for future commercial antimony production, with capacity modelling indicating potential refined antimony production of up to approximately 20,000 tpa, subject to feed grade, additional downstream refinery equipment and other operating requirements...
TransDigm Group Reports Fiscal 2026 Fourth Quarter and Year-End Results
CLEVELAND, Nov. 10, 2026 /PRNewswire/ -- TransDigm Group Incorporated (NYSE: TDG), a leading global designer, producer and supplier of highly engineered aircraft components, today reported results for the fourth quarter ended September 30, 2026. Fourth quarter highlights include: Net sales of $2,988 million, up 23% from $2,437 million in the prior year's quarter; Earnings per share of $10.33, up 33% from $7.75 in the prior year's quarter; EBITDA As Defined of $1,583 million, up 20% from $1,320 million in the prior year's quarter; and Adjusted earnings per share of $12.44, up 15% from $10.82 in the prior year's quarter...
Liquidia Corporation Reports Third Quarter 2026 Financial Results
MORRISVILLE, N.C., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company driven by science and compassion to revolutionize care for patients with challenging respiratory and vascular diseases, today reported financial results for the third quarter ended September 30, 2026. The company will also host a webcast at 8:30 a.m. ET on November 10, 2026, to discuss its financial results and provide a corporate update...
Bilt Selects Cerebras to Deliver Faster AI Experiences to More than Eight Million Members
New Bilt Neighborhood OS and personal assistant Bilt Concierge will be powered by Cerebras' high-speed AI infrastructure making everyday consumer experiences faster and more useful New Bilt Neighborhood OS and personal assistant Bilt Concierge will be powered by Cerebras' high-speed AI infrastructure making everyday consumer experiences faster and more useful
Resideo Launches Pro-IQ™ Predict, Bringing AI-Powered Predictive Intelligence to HVAC
Pro-IQ Predict uses connected-device intelligence to help spot HVAC system problems before they become breakdowns SCOTTSDALE, Ariz., Nov. 10, 2026 /PRNewswire/ -- HVAC systems tend to break when homeowners need them most: on the coldest night or hottest day of the year.
AEVEX Secures Nearly $400 Million IDIQ Award for Unmanned Aircraft Systems
SOLANA BEACH, Calif.--(BUSINESS WIRE)--AEVEX Corp. (NYSE: AVEX) today announced it has been awarded an Indefinite Delivery/Indefinite Quantity (IDIQ) contract with a ceiling of nearly $400 million for a U.S. customer.This multi-year award establishes a flexible contracting framework that enables the customer to procure unmanned aircraft systems and associated support services across a range of mission needs. The contract represents an important validation of the growing demand for adaptable, sca...
Nextdoor to Participate in Upcoming Investor Conferences
SAN FRANCISCO--(BUSINESS WIRE)--Nextdoor to participate in upcoming investor conferences.
Thompson Street Capital Partners Completes Growth Investment in Kinneberg Management Group
ST. LOUIS--(BUSINESS WIRE)--Thompson Street Capital Partners (TSCP), a private equity firm based in St. Louis, Missouri, announced today a growth investment in Kinneberg Management Group (“KMG”), a leading retail commerce enablement provider that helps consumer brands win and grow across the largest U.S. retail channels. Founder and CEO Doug Kinneberg will retain a significant ownership stake and continue to lead the company alongside its existing leadership team. Terms of the transaction were...
Venture Global Reports Third Quarter 2026 Results
ARLINGTON, Va.--(BUSINESS WIRE)--Venture Global Reports Third Quarter 2026 Results.
Suzano Publishes First Report Aligned With Taskforce on Nature-related Financial Disclosures Recommendations
SÃO PAULO, Brazil--(BUSINESS WIRE)--Suzano, the world's largest pulp producer, has published its first report aligned with the recommendations of the Taskforce on Nature-related Financial Disclosures (TNFD). The TNFD reporting framework helps organizations identify and assess how their dependencies and impacts may generate nature and biodiversity related risks and opportunities, and to disclose how they are integrated into the company's governance, strategy, and corporate management. Initially...
ENSG Investor Notification: Ensign Group Sued for Securities Fraud on behalf of Investors with Losses after Short Seller Report/Neglect Issues Lead to 8% Stock Drop
Ensign has been sued for securities fraud after its stock price fell following reports alleging that the company concealed patient neglect, understaffing, manipulated quality and staffing data, improper billing, and an administrator-license rental scheme. NEW YORK, Nov. 10, 2026 /PRNewswire/ -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against The Ensign Group, Inc. (NASDAQ:ENSG) and certain of the company's senior executives for securities fraud after significant stock drops resulting from potential violations of the federal securities laws...
FLNC Investor Notification: Fluence Energy Sued for Securities Fraud on behalf of Investors with Losses after Production Issues Lead to 34% Stock Drop
Fluence has been sued for securities fraud after its stock plummeted 35% because Fluence allegedly misrepresented the status of its manufacturing operations and ability to achieve its revenue and EBITDA guidance. NEW YORK, Nov. 10, 2026 /PRNewswire/ -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Fluence Energy, Inc. (NASDAQ:FLNC) and certain of the company's senior executives for securities fraud after significant stock drops resulting from potential violations of the federal securities laws...
ALHC Investor Notification: Alignment Healthcare Investigated for Securities Fraud on behalf of Investors with Losses after Inflated EBITDA Leads to 16% Stock Drop
BFA Law is investigating whether Alignment Healthcare, Inc. committed securities fraud relating to allegations that the company and its senior executives artificially inflated adjusted EBITDA to boost executive compensation. NEW YORK, Nov. 10, 2026 /PRNewswire/ -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Alignment Healthcare, Inc. (NASDAQ:ALHC) for potential securities fraud after its significant stock drop...